Christopher Gill

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

S. Park, Rosemarie Kelly, Jennifer Nielsen Kahn et al. · Antimicrobial Agents and Chemotherapy · 2005 · 426 citations · Full text

Diagnostic Mycology, Microbial Pathogens, Rare Laboratory +22

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

K Bartizal, Christopher Gill, George K. Abruzzo et al. · Antimicrobial Agents and Chemotherapy · 1997 · 312 citations · Full text

Antifungal Agent, Health Sciences, Antifungal Agents +12

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

George K. Abruzzo, Amy Flattery, Christopher Gill et al. · Antimicrobial Agents and Chemotherapy · 1997 · 244 citations · Full text

Covid-19 deaths in Africa: prospective systematic postmortem surveillance study

Lawrence Mwananyanda, Christopher Gill, William MacLeod et al. · BMJ · 2021 · 214 citations · Full text

Quantitative PCR Assay To Measure <i>Aspergillus fumigatus</i> Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate

Joel Bowman, George K. Abruzzo, Jennifer Anderson et al. · Antimicrobial Agents and Chemotherapy · 2001 · 208 citations · Full text

Diagnostic Mycology, Quantitative Pcr Assay, Immunology +17